Pharmaceutical Employer Market Strategies: Influencing the Influencers

Thursday, November 12, 2009 General News J E 4

CHAPEL HILL, N.C., Nov. 12 In an alternative and complementary approach to the current pharmaceutical commercial model, bio-pharmaceutical companies today are actively working to build consultative relationships with key employer decision makers, or those who determine company health care coverage.

"Serving the Healthcare Needs of Employers: Employer Market Strategies and Tactics," primary research by Best Practices, LLC, delivers benchmarks for pharmaceutical, biotechnology and medical device companies around staffing levels, organizational patterns and approaches, and budgets for working with large employers and employer coalitions. Executives from Bayer, Boehringer Ingelheim, Genentech, Novartis, Novo Nordisk and others contributed metrics, challenges and insights.

Download a research briefing of "Serving the Healthcare Needs of Employers: Employer Market Strategies and Tactics" at to view the study objective, key topic areas, other participating companies, executive quotes, selected key findings, metrics and best practices.

At large employers with more than 5000 employees, the primary target of pharma industry outreach, 73 percent of pharmaceutical account managers call on medical directors and human resource managers to begin raising awareness about disease states and treatment paradigms, according to the primary research.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or

BEST PRACTICES, LLC conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.

SOURCE Best Practices, LLC


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Biostar Pharmaceuticals, Inc. Announces Record Thi...
26 Technologies Receive 2009 Spine Technology Awar...